4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
News 2026-10-07 08:00 UTC
On Thursday, Ligand Pharmaceuticals (NASDAQ: LGND ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. The full earnings call is available at Summary Full Transcri
News 2026-05-28 17:58 UTC
BioPharma Credit Investments V files with SEC under Investment Company Act Section 3(c)(7).
News 2026-05-28 17:56 UTC
BioPharma Credit Investments V files with SEC under Investment Company Act Section 3(c)(7).
News 2026-05-28 17:54 UTC
BioPharma Credit Investments V LP files with SEC under Investment Company Act Section 3(c)(7).